Hepcdac 60mg tablets
Hepcdac is a preparation produced by the Indian company Cipla. The active substance is Daclatasvir in a standard dosage of 60 mg. It is intended for the successful treatment of hepatitis C in conjunction with the drug Sofosbuvir. Hepcdac is a panthenotypic NS5A protein inhibitor, so its task in treating hepatitis C is to block the virus in infected liver cells, preventing its further spread throughout the body. A distinctive feature of this drug is that it can be used for most genotypes, namely 1,2,3,4, which make it one of the unique medicines of our time. The proven effectiveness is at 95-99%. When buying Hepcdac the price in India is much lower than,
The composition includes Sofosbuvir (100 mg) and Daclatasvir (60 mg). In addition, there are a number of auxiliary substances, such as:
- Croscarmellose sodium
- Magnesium stearate
- Microcrystalline cellulose
- Iron Oxide Red
- Polyethylene glycol
- Polyvinyl alcohol
- Titanium dioxide
The medicine is recommended once a day at the same time with another medicine of complex therapy – Sofosbuvir. The standard dose is 60 mg for Daclatasvir and 400 mg for Sofosbuvir. The total duration of the application is 12 weeks with the standard course; however, the physician can prescribe a 24-week course based on the patient’s analysis. Treatment should be discontinued if there is no sustained virology response at the end of the month. Patients older than 60 years do not need a dose adjustment with respect to age.
The patients should contact the doctors if they receive side effects on the relationship to Daclatasvir as Vertigo, without feeling well, Fatigue, weakness, Chest pain, Headache, Anemia.
Keep the drug is recommended in a dry, protected from sunlight, at a temperature of +15 to +30 C.
If you need Hepcdac you can buy it in our online store, at the lowest prices.